Testing effectiveness (Phase 2)Study completedNCT02230761
What this trial is testing
Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Who this might be right for
Lower Eyelid Steatoblepharon (Excess Eyelid Fat)
Topokine Therapeutics, Inc. 90